Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2010
10/13/2010CN101856352A Synergistic effect of arteannuim and derivative thereof on chemotherapeutic agent
10/13/2010CN101856347A Extract of leontopodic acid plant and application of active ingredients thereof in treating hepatitis
10/13/2010CN101856332A Method for preparing 8, 9-single-epoxy brevifolin PLGA microspheres
10/13/2010CN101856324A Method for preparing phloroglucinol injection
10/13/2010CN101502631B Synergistic medicament composition containing Aolamite and Chinese medicine extract
10/13/2010CN101502589B Chinese and western medicinal composition containing bifendate for auxiliary treatment of hepatitis
10/13/2010CN101502572B Auxiliary Chinese and western medicinal composition for treating hepatitis
10/13/2010CN101502551B Synergistic composition containing bifendate
10/13/2010CN101496846B Medicament composition containing bifendate and Chinese medicine extract
10/13/2010CN101496578B Special diet and foodstuffs formula containing small peptide for hepatopath
10/13/2010CN101411717B Composition for treating acute enteritis and diarrhea
10/13/2010CN101342253B Traditional Chinese medicine preparation for treating chronic gastritis
10/13/2010CN101342187B Medicament composition for treating dysentery
10/13/2010CN101328469B Streptococcus thermophilus grx02 having alcoholic liver damage protection function and use thereof
10/13/2010CN101274024B Pharmaceutical compositions for curing toothache
10/13/2010CN101264251B Chinese traditional medicine for treating vertigo
10/13/2010CN101255157B Crystal system of chlorhydric acid palonosetron and preparation method thereof
10/13/2010CN101244151B Medicament for treating dysentery
10/13/2010CN101204565B Peroral Chinese traditional medicine prescripton for superficial gastritis
10/13/2010CN101199741B Capsule and preparing method thereof
10/13/2010CN101181547B Chinese medicine for curing halitosis, dry mouth, bitter taste and mouth ulcer
10/13/2010CN101167829B Traditional Chinese medicinal composition and enema for treating chronic colitis and preparation method thereof
10/13/2010CN101036760B Composition having stomachic, liver-care, and hypermnesia functions and the preparing technique
10/13/2010CN101019971B Compound Chinese medicine preparation for treating hepatitis B and its preparation process
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812146 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
10/12/2010US7812054 administering methyl (E,5S,6R)-5,6-dihydroxy-8-[2-[(E,3R)-3-hydroxyoct-1-enyl]phenyl]oct-7-enoate, optionally with a cyclooxygenase inhibitor selected from celecoxib, rofecoxib, and valdecoxib, to humans or animals for the treatment of an oral inflammation
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812004 For modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine; anticancer agents; dietary fibre effects, improved mineral absorption (calcium and magnesium), for treating osteoporosis
10/12/2010US7811818 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders; useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products
10/12/2010US7811609 Use of metal compounds to treat gastrointestinal infections
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2620738C Tablet for removing tongue coating
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2375599C Probiotic compositions comprising e. coli and volatile fractions of plant extracts
10/12/2010CA2338946C Hepatitis c inhibitor tri-peptides
10/07/2010WO2010115055A1 L-ornithine phenyl acetate and methods of making thereof
10/07/2010WO2010114864A1 Probiotic oral dosage forms
10/07/2010WO2010114533A1 Anti-biofilm carbonate compounds for use in oral care compositions
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010113960A1 Agent for inhibiting thickening of peritoneal membrane
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113841A1 Orally disintegrating coated tablet
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113801A1 Tooth calcification agent and method for producing same
10/07/2010WO2010113800A1 Dentine calcification agent and method for producing same
10/07/2010WO2010113631A1 Agent for amelioration or prevention of metabolic syndrome
10/07/2010WO2010113458A1 Method for manufacturing benzodiazepine derivative
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112865A1 5-ht receptor modulating compounds
10/07/2010WO2010112578A1 4 -isopropyl-3-methylphenol for the treatment of inflammation
10/07/2010WO2010078833A8 Modified sodium-montmorillonite, preparing method and uses thereof
10/07/2010WO2010063470A9 Methods for preventing or reducing colon carcinogenesis
10/07/2010US20100256239 Anthracenedione compounds
10/07/2010US20100256231 Novel derivatives of 3,3-diphenylpropylamines
10/07/2010US20100256230 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
10/07/2010US20100256229 Compositions of cholinesterase inhibitors
10/07/2010US20100256213 Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolidin-1-YL-Methyl)-Phenyl] Cyclobut Anecarboxamide
10/07/2010US20100256210 Methods and compositions for delivering 5-ht3 antagonists across the oral mucosa
10/07/2010US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor
10/07/2010US20100256202 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
10/07/2010US20100256198 Method for decreasing symptoms of alcohol consumption
10/07/2010US20100256157 Method of treatment
10/07/2010US20100256140 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives
10/07/2010US20100256132 Il-12 modulatory compounds
10/07/2010US20100256129 Selective androgen receptor modulators (sarms) and uses thereof
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255122 Edible gelatin bowel preparation and bowel cleansing method
10/07/2010US20100255119 Mucositis Prevention Supplement and Treatment
10/07/2010US20100255096 Compositions And Methods For Transmucosal Delivery Of Domperidone
10/07/2010US20100255091 Oral fast disintegrating tablets
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255078 Serpin drugs for treatment of viral infection and method of use thereof
10/07/2010US20100255077 Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
10/07/2010US20100255066 Orally-administered agent
10/07/2010US20100255062 Compounds, polymers and methods for treating gastrointestinal dysfunction
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100254995 Polypeptides, antibody variable domains and antagonists
10/07/2010US20100254979 Humanized PAI-1 Antibodies and Uses Thereof
10/07/2010US20100254975 Alpha-4 beta-7 heterodimer specific
10/07/2010US20100254972 Methods for selecting protease resistant polypeptides
10/07/2010US20100254971 Method for Diagnosing Prognosing Inflammatory Bowel Disease and Crohn's Disease
10/07/2010US20100254953 Cell growth method and pharmaceutical preparation for tissue repair and regeneration
10/07/2010US20100254949 Prebiotic oligosaccharides
10/07/2010US20100254918 Agent for the prevention and treatment of the initial dental caries
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757373A1 L-ornithine phenyl acetate and methods of making thereof
10/07/2010CA2757208A1 Method for manufacturing 1,5-benzodiazepine derivative
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2757106A1 5-ht receptor modulating compounds
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010CA2756877A1 Orally disintegrating coated tablet
10/07/2010CA2753658A1 Anti-biofilm carbonate compounds for use in oral care compositions
1 ... 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 ... 1258